ProShares Etf Valuation


USD 30.97  0.27  0.86%   

Do you wonder what the value of ProShares Nanotechnology is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as ProShares Nanotechnology, is its stock price multiplied by the total number of shares outstanding, calculating ProShares Nanotechnology's enterprise value requires a different approach. It uses ProShares Nanotechnology's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
ProShares Nanotechnology Enterprise Value is fairly stable at the moment as compared to the past year. ProShares Nanotechnology reported Enterprise Value of 59.29 Million in 2021. Tangible Asset Value is likely to rise to about 132.4 M in 2022, whereas Free Cash Flow is likely to drop (6 M) in 2022.
ProShares Nanotechnology holds a recent Real Value of $30.22 per share. The prevailing price of the etf is $30.97. At this time, the etf appears to be overvalued. Our model determines the value of ProShares Nanotechnology from analyzing the etf fundamentals such as Return On Asset of (0.03) %, shares owned by insiders of 7.58 %, and Current Valuation of 51.56 M as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
ProShares Nanotechnology Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ProShares Nanotechnology's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Today 30.97
Please note that ProShares Nanotechnology's price fluctuation is very steady at this time. Calculation of the real value of ProShares Nanotechnology is based on 3 months time horizon. Increasing ProShares Nanotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ProShares Nanotechnology ETF is useful when determining the fair value of the ProShares etf, which is usually determined by what a typical buyer is willing to pay for full or partial control of ProShares Nanotechnology. Since ProShares Nanotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProShares Etf. However, ProShares Nanotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of ProShares Nanotechnology ETF helps investors to forecast how ProShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProShares Nanotechnology more accurately as focusing exclusively on ProShares Nanotechnology's fundamentals will not take into account other important factors:
LowEstimated ValueHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ProShares Nanotechnology's intrinsic value based on its ongoing forecasts of ProShares Nanotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ProShares Nanotechnology's closest peers. When choosing an evaluation method for ProShares Nanotechnology, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

ProShares Nanotechnology Investments

113.5 Million

ProShares Valuation Drivers Correlation

Many accounts on the financial statements of ProShares Nanotechnology are highly interrelated and sometimes correlated. Consequently, when conducting ProShares's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of ProShares
Click cells to compare fundamentals

ProShares Valuation Trend

Knowing ProShares Nanotechnology's actual value is paramount for traders to make sound investment determinations. ProShares Nanotechnology's real value is not only important for the investor to make better decisions but also for a more accurate overall view of ProShares Nanotechnology's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both ProShares Nanotechnology's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

ProShares Market Cap

ProShares Nanotechnology ETF is presently regarded as number one ETF in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Technology category is currently estimated at about 146.33 Billion. ProShares Nanotechnology adds roughly 1.92 Million in net asset claiming only tiny portion of equities under Technology ETF category.

ProShares Nanotechnology Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ProShares Nanotechnology's current stock value. Our valuation model uses many indicators to compare ProShares Nanotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ProShares Nanotechnology competition to find correlations between indicators driving ProShares Nanotechnology's intrinsic value. More Info.
ProShares Nanotechnology ETF is presently regarded as number one ETF in beta as compared to similar ETFs. It is presently regarded as number one ETF in equity positions weight as compared to similar ETFs making about  284.86  of Equity Positions Weight per Beta. Average Equity is likely to drop to about 26.6 M in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value ProShares Nanotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ProShares Nanotechnology's Etf . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ProShares Nanotechnology's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ProShares Nanotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ProShares Nanotechnology and how it compares across the competition.

About ProShares Nanotechnology Valuation

The etf valuation mechanism determines the current worth of ProShares Nanotechnology ETF on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ProShares Nanotechnology ETF. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of ProShares Nanotechnology based exclusively on its fundamental and basic technical indicators. By analyzing ProShares Nanotechnology's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ProShares Nanotechnology's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProShares Nanotechnology. We calculate exposure to ProShares Nanotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ProShares Nanotechnology's related companies.
Last ReportedProjected for 2022
Gross Profit1.1 M1.2 M
Profit Margin(53.91) (58.17) 
ProShares Nanotechnology's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether ProShares Nanotechnology's value is low or high relative to the company's performance and growth projections. Determining the market value of ProShares Nanotechnology can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of ProShares Nanotechnology represents a small ownership stake in the entity. As a stockholder of ProShares, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

ProShares Nanotechnology Dividends Analysis For Valuation

Please note that ProShares Nanotechnology has scaled down on payment of dividends at this time. Accumulated Retained Earnings Deficit is likely to drop to about (145.5 M) in 2022. Earning Before Interest and Taxes EBIT is likely to drop to about (23 M) in 2022
There are various types of dividends ProShares Nanotechnology can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of ProShares shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from ProShares Nanotechnology ETF directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When ProShares pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of ProShares Nanotechnology by the value of the dividends paid out.
Additionally, take a look at World Market Map. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running ProShares Nanotechnology price analysis, check to measure ProShares Nanotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProShares Nanotechnology is operating at the current time. Most of ProShares Nanotechnology's value examination focuses on studying past and present price action to predict the probability of ProShares Nanotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ProShares Nanotechnology's price. Additionally, you may evaluate how the addition of ProShares Nanotechnology to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEO Directory
Screen CEOs from public companies around the world
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Bond Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine ProShares Nanotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.